Bio-Techne (TECH) Profit After Tax Growth (3y) (2012 - 2026)
Bio-Techne (TECH) Profit After Tax Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | 9.53% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn | -27.65% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | 70.25% |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn | 47.10% |
| 10 | Bio-Techne | 11.21 Bn | 11.00 Bn | 208.29 Mn | -10.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.08% |
| Dec 31, 2025 | -7.12% |
| Sep 30, 2025 | -27.87% |
| Jun 30, 2025 | 60.08% |
| Mar 31, 2025 | -24.46% |
| Dec 31, 2024 | -49.42% |
| Sep 30, 2024 | -21.32% |
| Jun 30, 2024 | 52.63% |
| Mar 31, 2024 | 2.33% |
| Dec 31, 2023 | -3.23% |
| Sep 30, 2023 | 15.15% |
| Jun 30, 2023 | 8.65% |
| Mar 31, 2023 | 24.45% |
| Dec 31, 2022 | -25.23% |
| Sep 30, 2022 | 84.03% |
| Jun 30, 2022 | -148.32% |
| Mar 31, 2022 | 10.80% |
| Dec 31, 2021 | 60.11% |
| Sep 30, 2021 | 58.26% |
| Jun 30, 2021 | -34.57% |